Yesterday, our paper addressing how disaster risk in conflict areas can be reduced to meet United Nations Sendai Framework disaster risk reduction priorities was presented at Conflict Research Society’s annual conference.
Monday morning and news arrived that FDA fully approves Pfizer / BioNTech SE Coronavirus Vaccine as the first COVID-19 vaccine for prevention of #COVID19 disease in 16 years of age and older.
Start Time: Wed 12am GMT / End Time: Thurs 1am GMT
|Time (GMT)||@GlobalHealthCH Moderator(s)||Room Topic|
|12am||Chidi Nwankpa (@chidnwankpa), Tamsin Meekel & Sonny Patel (@sonnypatel)||Impacting Global Health Through CH #WHD2021|
|2am||Ashley Allison (@MsAshleyIndira)||Quality for All? Racism and Inequity in Healthcare #WHD2021|
|2pm||Sam Lippolis (@samiamlip) & Sonny Patel (@sonnypatel) [Collaboration w/ @MedTechClub]||Weekly Connections in Global Health: Changemakers & VCs #WHD2021 |
|4pm||Donna Patterson (@PharmacySenegal)||Global Response to COVID in Different Regions – Are we meeting our goals? #WHD2021|
|6pm||Grace Gabagaya (@DrG_Omukali)||Vaccine Equity in a Fairer and Healthier World #WHD2021|
|8pm||Tan Rasab (@sigenexinc) & Sonny Patel (@sonnypatel)||Side effects of focusing all health on COVID #WHD2021|
|10pm||Zabin Patel (zabinsp), Aqsa Suleman (@aqsa_sz) & Sonny Patel (@sonnypatel)||Should decolonization of Global Health happen? #WHD2021|
|12am||Maria Eduarda Mesquita (@Duda_Mesquita) & Lucas Ponte (@Lucaspontelol)||Surgery as Solution for Universal Health Coverage? #WHD2021|
A simple mix up of ingredients for the Johnson & Johnson and AstraZeneca/University of Oxford coronavirus vaccines was said to occur at Emergent BioSolutions plant.
A constant question to me – where are the Johnson & Johnson vaccines?
“Vaccine for the world” – COVID-19 Vaccine by Oxford University and AstraZeneca was found to be 79 % effective against symptomatic COVID-19 and 100 % effective against severe illness. New clinical study data was released from recent studies carried out in United States, Chile and Peru. Including 32,449 adult participants in all age groups (most from United States), the study participants received either two doses of the Oxford-AstraZeneca vaccine or a placebo between four-week time. The two-shot system was completely effective at preventing severe cases of illness in the new studies. Five cases of severe illness were found in the new studies – all of them had received a placebo.
100 million doses for US by the end of June 2021! A third COVID-19 vaccine option is now available in US. About 500 million doses are being purchased through Covax scheme for many global countries as well.